A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion(Institute of Cancer Research), Pascal Meier(Breast Cancer Research Foundation)
Cited by 80
Related Papers
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
|Molecular Cell|2017|323
The unconventional myosin CRINKLED and its mammalian orthologue MYO7A regulate caspases in their signalling roles
|Nature Communications|2016|35